NewsBenzingaKaryopharm Therapeutics Enters Restructuring Agreement With Lenders, Clearing Path For A Merger With Ayrmid; Secures Commitments For Up To $55M Of Debtor-In-Possession Financing Karyopharm Therapeutics Enters Restructuring Agreement With Lenders, Clearing Path For A Merger With Ayrmid; Secures Commitments For Up To $55M Of Debtor-In-Possession Financing Benzinga 2026.11.02 12:16 (GMT+0) Open on Benzinga Other news POET Technologies Gets a New CFO Ahead of Its Nov. 16 Earnings Report Wells Fargo Maintains Overweight on LyondellBasell Industries, Raises Price Target to $76 Guggenheim Maintains Buy on First Solar, Lowers Price Target to $297 Wells Fargo Maintains Equal-Weight on nVent Electric, Raises Price Target to $190 Guggenheim Maintains Buy on Regeneron Pharmaceuticals, Raises Price Target to $1100 Foreign Media: Apple's Home Robot Launch May Be Delayed to 2028
